0
Skip to Content
BLOODPAC
BLOODPAC
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
BLOODPAC Portal
BLOODPAC Data Commons
Educational Seminars
Upcoming Events
BLOODPAC Publications
Data Elements
Frameworks & Standards
Member Publications
BLOODPAC Dictionary
BLOODPAC Governance
Beyond ctDNA
Insights
Job Opportunities
Videos
MEMBER LOGIN
BLOODPAC
BLOODPAC
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
BLOODPAC Portal
BLOODPAC Data Commons
Educational Seminars
Upcoming Events
BLOODPAC Publications
Data Elements
Frameworks & Standards
Member Publications
BLOODPAC Dictionary
BLOODPAC Governance
Beyond ctDNA
Insights
Job Opportunities
Videos
MEMBER LOGIN
Folder: About
Back
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Folder: Approach
Back
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Folder: Data
Back
BLOODPAC Portal
BLOODPAC Data Commons
Folder: Events
Back
Educational Seminars
Upcoming Events
Folder: Impact
Back
BLOODPAC Publications
Data Elements
Frameworks & Standards
Member Publications
Folder: Resources
Back
BLOODPAC Dictionary
BLOODPAC Governance
Beyond ctDNA
Insights
Job Opportunities
Videos
MEMBER LOGIN
Thought Leaders in Liquid Biopsy: Dr. Howard Scher (Memorial Sloan Kettering Cancer Center)
Member Spotlight Guest User 3/21/23 Member Spotlight Guest User 3/21/23

Thought Leaders in Liquid Biopsy: Dr. Howard Scher (Memorial Sloan Kettering Cancer Center)

Read More
Understanding Molecular Residual Disease (MRD) in Solid Tumors
Liquid Biopsy Technology Guest User 3/13/23 Liquid Biopsy Technology Guest User 3/13/23

Understanding Molecular Residual Disease (MRD) in Solid Tumors

Read More
Thought Leaders in Liquid Biopsy: A Conversation with Dr. Anne-Marie Martin (Global Head of Experimental Medicine, GSK)
Member Spotlight Guest User 3/10/23 Member Spotlight Guest User 3/10/23

Thought Leaders in Liquid Biopsy: A Conversation with Dr. Anne-Marie Martin (Global Head of Experimental Medicine, GSK)

Read More
Understanding Tumor Mutational Burden (TMB)
Liquid Biopsy Technology Guest User 3/7/23 Liquid Biopsy Technology Guest User 3/7/23

Understanding Tumor Mutational Burden (TMB)

Read More
Thought Leaders in Liquid Biopsy: A Conversation with Dr. Phil Febbo (CMO, Illumina)
Member Spotlight Guest User 3/2/23 Member Spotlight Guest User 3/2/23

Thought Leaders in Liquid Biopsy: A Conversation with Dr. Phil Febbo (CMO, Illumina)

Read More
Contrived Materials in Liquid Biopsy Assay Development
Liquid Biopsy Technology Guest User 2/27/23 Liquid Biopsy Technology Guest User 2/27/23

Contrived Materials in Liquid Biopsy Assay Development

Read More
New Paper on Contrived Materials in Liquid Biopsy Validation from BLOODPAC
News Guest User 2/22/23 News Guest User 2/22/23

New Paper on Contrived Materials in Liquid Biopsy Validation from BLOODPAC

Read More
BLOODPAC Publishes a Roadmap for Early Cancer Detection and Screening using Liquid Biopsy
News Guest User 2/22/23 News Guest User 2/22/23

BLOODPAC Publishes a Roadmap for Early Cancer Detection and Screening using Liquid Biopsy

Read More
BLOODPAC Hosts Brain Cancer Virtual Webinar
News Laura Tramontozzi 7/14/22 News Laura Tramontozzi 7/14/22

BLOODPAC Hosts Brain Cancer Virtual Webinar

Read More
BLOODPAC and Epic Sciences: Building Collaboration
News Laura Tramontozzi 6/4/20 News Laura Tramontozzi 6/4/20

BLOODPAC and Epic Sciences: Building Collaboration

Read More
BLOODPAC Working Group Publishes on COVID-19 Testing Requirements
News Laura Tramontozzi 4/2/20 News Laura Tramontozzi 4/2/20

BLOODPAC Working Group Publishes on COVID-19 Testing Requirements

Read More
College of American Pathologists extends support of BLOODPAC’s MTDEs
News Laura Tramontozzi 6/15/18 News Laura Tramontozzi 6/15/18

College of American Pathologists extends support of BLOODPAC’s MTDEs

Read More
BloodPAC Moves Forward With Liquid Biopsy Data Commons</a>
News Laura Tramontozzi 3/2/18 News Laura Tramontozzi 3/2/18

BloodPAC Moves Forward With Liquid Biopsy Data Commons

Read More
Breast Cancer Research Foundation &amp; Prostate Cancer Foundation Commit to Supporting BLOODPAC
News Laura Tramontozzi 12/20/16 News Laura Tramontozzi 12/20/16

Breast Cancer Research Foundation & Prostate Cancer Foundation Commit to Supporting BLOODPAC

Read More
Blood Profiling Atlas in Cancer: Identifying the Mission
News Laura Tramontozzi 11/30/16 News Laura Tramontozzi 11/30/16

Blood Profiling Atlas in Cancer: Identifying the Mission

Read More
Public &amp; Private Sector Actions to Advance Cancer Moonshot Goals</a>
News Laura Tramontozzi 10/17/16 News Laura Tramontozzi 10/17/16

Public & Private Sector Actions to Advance Cancer Moonshot Goals

Read More
Newer Posts

ABOUT

BLOODPAC is a consortium managed by the Center for Computational Science Research, Inc. (CCSR), which is an Illinois based 501 (c)(3) not-for-profit corporation. Our mission is to accelerate the development, validation, and accessibility of liquid biopsy assays to improve outcomes for patients with cancer. To do so, we lead a pre-competitive collaborative infrastructure that enables the sharing of information and building of consensus among stakeholders in industry, academia, regulatory bodies, payers, and government agencies.